| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology and Genetics |
Research Division, Joslin Diabetes Center, Department of Medicine, Harvard Medical School, Boston, Massachusetts 02215 [Y-H. T., D. V., J. Z., J. S. M., C. R. K.]; and Department of Pathology, University of Manitoba, Winnipeg, Manitoba R3E OW3, Canada [Y. N., A. A., P. H. W.]
Rad is the prototypic member of a family of novel Ras-related GTPases that is normally expressed in heart, skeletal muscle, and lung and that has been shown to exhibit a novel form of bi-directional interaction with the nm23 metastasis suppressor. In the present study, we have investigated the expression of Rad in normal and neoplastic breast tissues by Western blot and immunohistochemistry and the functional effect of altered Rad expression in breast cancer cell lines. We found that, although Rad is frequently expressed in normal breast tissue (23/30 Rad+ve), expression is usually lost in adjacent invasive carcinoma (8/30 Rad+ve; P < 0.0001). However, where Rad expression persists in a small proportion of tumors, it is associated with higher grade, larger size, and extensive axillary nodal involvement (n = 48; P = 0.035, P = 0.016, P = 0.022, respectively). Furthermore, Rad is also highly expressed in a breast cancer cell line with high tumorigenic and metastatic potential (MDA-MB231). To further examine the role of Rad in breast cancer, we stably transfected a Rad-ve breast cancer cell line (MDA-MB435). We observed an increase in growth and marked increased colony formation in soft agar in vitro (P < 0.05) and an increase in tumor growth rate in nude mice (P < 0.05). Moreover, coexpression of nm23 with wild-type Rad inhibited the effect of Rad on growth of these cells in culture and markedly inhibited tumor growth in vivo. Additional transfection studies with mutated Rad cDNAs revealed that the growth-promoting effects of Rad appeared to be mediated through its NH2- and COOH-terminal regions, rather than its GTPase domain, and might involve acceleration of cell cycle transition. These findings suggest that Rad may act as an oncogenic protein in breast tissues and demonstrate a potential mechanism by which interaction between Rad and nm23 may regulate growth and tumorigenicity of breast cancer.
This article has been cited by other articles:
![]() |
J. A. Woolworth, G. Nallamothu, and T. Hsu The Drosophila Metastasis Suppressor Gene Nm23 Homolog, awd, Regulates Epithelial Integrity during Oogenesis Mol. Cell. Biol., September 1, 2009; 29(17): 4679 - 4690. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Nallamothu, J. A. Woolworth, V. Dammai, and T. Hsu awd, the Homolog of Metastasis Suppressor Gene Nm23, Regulates Drosophila Epithelial Cell Invasion Mol. Cell. Biol., March 15, 2008; 28(6): 1964 - 1973. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Chang, J. Zhang, Y.-H. Tseng, C.-Q. Xie, J. Ilany, J. C. Bruning, Z. Sun, X. Zhu, T. Cui, K. A. Youker, et al. Rad GTPase Deficiency Leads to Cardiac Hypertrophy Circulation, December 18, 2007; 116(25): 2976 - 2983. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kaul, M. Murakami, T. Choudhuri, and E. S. Robertson Epstein-Barr Virus Latent Nuclear Antigens Can Induce Metastasis in a Nude Mouse Model J. Virol., October 1, 2007; 81(19): 10352 - 10361. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Yanuar, S. Sakurai, K. Kitano, and T. Hakoshima Crystal structure of human Rad GTPase of the RGK-family. Genes Cells, August 1, 2006; 11(8): 961 - 968. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ilany, P. J. Bilan, S. Kapur, J. S. Caldwell, M.-E. Patti, A. Marette, and C. R. Kahn Overexpression of Rad in muscle worsens diet-induced insulin resistance and glucose intolerance and lowers plasma triglyceride level PNAS, March 21, 2006; 103(12): 4481 - 4486. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Hawke, S. B. Kanatous, C. M. Martin, S. C. Goetsch, and D. J. Garry Rad is temporally regulated within myogenic progenitor cells during skeletal muscle regeneration Am J Physiol Cell Physiol, February 1, 2006; 290(2): C379 - C387. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Boissan, D. Wendum, S. Arnaud-Dabernat, A. Munier, M. Debray, I. Lascu, J.-Y. Daniel, and M.-L. Lacombe Increased Lung Metastasis in Transgenic NM23-Null/SV40 Mice with Hepatocellular Carcinoma J Natl Cancer Inst, June 1, 2005; 97(11): 836 - 845. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Beguin, R. N. Mahalakshmi, K. Nagashima, D. H. K. Cher, A. Takahashi, Y. Yamada, Y. Seino, and W. Hunziker 14-3-3 and calmodulin control subcellular distribution of Kir/Gem and its regulation of cell shape and calcium channel activity J. Cell Sci., May 1, 2005; 118(9): 1923 - 1934. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sasaki, T. Shibasaki, P. Beguin, K. Nagashima, M. Miyazaki, and S. Seino Direct Inhibition of the Interaction between {alpha}-Interaction Domain and {beta}-Interaction Domain of Voltage-dependent Ca2+ Channels by Gem J. Biol. Chem., March 11, 2005; 280(10): 9308 - 9312. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Salerno, D. Palmieri, A. Bouadis, D. Halverson, and P. S. Steeg Nm23-H1 Metastasis Suppressor Expression Level Influences the Binding Properties, Stability, and Function of the Kinase Suppressor of Ras1 (KSR1) Erk Scaffold in Breast Carcinoma Cells Mol. Cell. Biol., February 15, 2005; 25(4): 1379 - 1388. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Steeg PERSPECTIVES ON CLASSIC ARTICLES: Metastasis Suppressor Genes J Natl Cancer Inst, March 17, 2004; 96(6): E4 - E4. [Full Text] |
||||
![]() |
P. LOREA, H. VAN DE WALLE, L. KINNEN, P. LEDOUX, J-P. MOERMANS, and B. VAN DEN HEULE Giant Cell Tumours of the Tendon Sheath: Lack of Correlation between nm23-H1 Expression and Recurrence J Hand Surg Eur Vol., February 1, 2004; 29(1): 67 - 70. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Aguirre-Ghiso, Y. Estrada, D. Liu, and L. Ossowski ERKMAPK Activity as a Determinant of Tumor Growth and Dormancy; Regulation by p38SAPK Cancer Res., April 1, 2003; 63(7): 1684 - 1695. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. F. Kalejta and T. Shenk The Human Cytomegalovirus UL82 Gene Product (pp71) Accelerates Progression through the G1 Phase of the Cell Cycle J. Virol., March 15, 2003; 77(6): 3451 - 3459. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Watson, D. H. Gutmann, K. Peterson, M. R. Chicoine, B. K. Kleinschmidt-DeMasters, H. G. Brown, and A. Perry Molecular Characterization of Human Meningiomas by Gene Expression Profiling Using High-Density Oligonucleotide Microarrays Am. J. Pathol., August 1, 2002; 161(2): 665 - 672. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ichigotani, S. Yokozaki, Y. Fukuda, M. Hamaguchi, and S. Matsuda Forced Expression of NESH Suppresses Motility and Metastatic Dissemination of Malignant Cells Cancer Res., April 1, 2002; 62(8): 2215 - 2219. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |